“Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for March 2024 the Company recorded a decrease in sales of 24% compared to the same month of the previous year, incl. 8% decrease in domestic sales and 32% decrease in export sales, mainly due to destabilizing market dynamics on the main export destinations.

From the beginning of 2024, the Company recorded a decrease in sales of 11%, incl. 1% decrease of domestic sales and 16% decrease in export sales.

Sofia, Bulgaria, March 20, 2024 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for February 2024 the Company recorded an decrease in sales of 29% compared to the same month of the previous year, incl. 9% decrease in domestic sales and 43% decrease in export sales.

From the beginning of 2024, the Company recorded a decrease in sales of 3%, incl. 2% growth in domestic sales and 7% decrease in export sales.